While less effective, they provide a baseline option that is always accessible regardless of insurance decisions, pharmacy stock levels, or regulatory changes
Zepbound is FDA-approved semaglutide, while PlexusDx offers compounded tirzepatide injection from licensed 503A pharmacies at $289/mo month-to-month, or from $249/mo on the 6-month plana dual GLP-1/GIP receptor agonist often associated with larger weight loss and cardiovascular benefits
Mitochondrial dysfunction can drive senescence via reactive oxygen species (ROS) accumulation [68, 69], and Tat ( morphine) perturbs mitochondrial function, increasing ROS, protein oxidation, and cytokine release in microglia [60, 70]
The compounded GLP-1 medications that may be prescribed through affiliated providers are also not FDA-approved
Hence, even now, and despite the knowledge that APAP can cause hepatotoxicity in overdose, and the extensive research that has been conducted on its pharmacokinetics and mechanisms of toxicity over the years, there is still no quantitative model for predicting de novo the dose level at which hepatotoxicity will occur in humans and how this will vary with metabolic activity.70 Ultimately the decision to progress the development of APAP would then come down to potential risk versus benefit
